Cargando…

Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics

BACKGROUND: Italy was the first Western country to be hit by the SARS-CoV-2 epidemic. There is now mounting evidence that a minority of children infected with SARS-CoV2 may experience a severe multisystem inflammatory syndrome, called Multisystem inflammatory Syndrome associated with Coronavirus Dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cattalini, Marco, Taddio, Andrea, Bracaglia, Claudia, Cimaz, Rolando, Paolera, Sara Della, Filocamo, Giovanni, La Torre, Francesco, Lattanzi, Bianca, Marchesi, Alessandra, Simonini, Gabriele, Zuccotti, Gianvincenzo, Zunica, Fiammetta, Villani, Alberto, Ravelli, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868856/ https://www.ncbi.nlm.nih.gov/pubmed/33557873 http://dx.doi.org/10.1186/s13052-021-00980-2

Ejemplares similares

Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey
por: Cattalini, Marco, et al.
Publicado: (2021)

Predictors of relapse after discontinuing systemic treatment in autoimmune chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2014)

Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study
por: Licciardi, Francesco, et al.
Publicado: (2023)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2013)

What is the future of targeted therapy in rheumatology: biologics or small molecules?
por: Mócsai, Attila, et al.
Publicado: (2014)

Multi-Inflammatory Syndrome in Children (MIS-C) in 2023: Is It Time to Forget about It?
por: La Torre, Francesco, et al.
Publicado: (2023)

Translating academic research into guidance to support healthcare improvement: how should guidance development be reported?
por: Turner, Simon, et al.
Publicado: (2019)

The (Mis)appropriation of HIV/AIDS advocacy strategies in Global Mental Health: towards a more nuanced approach
por: Howell, Alison, et al.
Publicado: (2017)

Where Is Pediatric Rheumatology Going, and Why a New Section of Frontiers in Pediatrics?
por: Cimaz, Rolando
Publicado: (2020)

Psychosocial, behavioural, pedagogical, and nutritional proposals about how to encourage eating a healthy breakfast
por: Mameli, Chiara, et al.
Publicado: (2014)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
por: Simonini, G, et al.
Publicado: (2011)

Ethics parallel research: an approach for (early) ethical guidance of biomedical innovation
por: Jongsma, Karin R., et al.
Publicado: (2020)

HIV prevention research and COVID-19: putting ethics guidance to the test
por: Rennie, Stuart, et al.
Publicado: (2021)

Supporting ALL victims of violence, abuse, neglect or exploitation: guidance for health providers
por: Viergever, Roderik F, et al.
Publicado: (2018)

Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic
por: Della Paolera, Sara, et al.
Publicado: (2021)

Cardiac MRI in midterm follow-up of MISC: a multicenter study
por: Benvenuto, Simone, et al.
Publicado: (2022)

Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome
por: Caldarale, Francesca, et al.
Publicado: (2021)

Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy
por: Costi, Stefania, et al.
Publicado: (2020)

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children
por: Usonis, Vytautas, et al.
Publicado: (2010)

Defining the process to literature searching in systematic reviews: a literature review of guidance and supporting studies
por: Cooper, Chris, et al.
Publicado: (2018)

Bin it or pin it? Which professional ethical guidance on managing COVID-19 should I follow?
por: Huxtable, Richard
Publicado: (2020)

Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
por: Munn, Zachary, et al.
Publicado: (2018)

Wishful thinking versus operational commitment: is the international guidance on priority sexual and reproductive health interventions in humanitarian settings becoming unrealistic?
por: Tran, Nguyen Toan, et al.
Publicado: (2018)

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease
por: Marchesi, Alessandra, et al.
Publicado: (2021)

The Multisystem Inflammatory Syndrome of Childhood (MIS-C)
por: Sinaei, Reza, et al.
Publicado: (2021)

Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Patel, Julisa M.
Publicado: (2022)

When flexibility is not necessarily a virtue: a review of hypermobility syndromes and chronic or recurrent musculoskeletal pain in children
por: Cattalini, Marco, et al.
Publicado: (2015)

Secondary prophylaxis in rheumatic fever: is it time to change?
por: Taddio, Andrea, et al.
Publicado: (2015)

Cardiovascular Manifestations in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 According to Age
por: Campanello, Claudia, et al.
Publicado: (2022)

Allergy and autoimmunity in children: non-mutually exclusive diseases. A narrative review
por: D’Auria, Enza, et al.
Publicado: (2023)

The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Panaro, Salvatore, et al.
Publicado: (2021)

Multisystem inflammatory syndrome in children (MIS-C) and “Near MIS-C”: A continuum?
por: Khafaja, Sarah, et al.
Publicado: (2023)

Fluid overload in the ICU: evaluation and management
por: Claure-Del Granado, Rolando, et al.
Publicado: (2016)

Atypical Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Acharya, Suchi, et al.
Publicado: (2021)

Childhood multisystem inflammatory syndrome associated with COVID‐19 (MIS‐C): Distinct from Kawasaki disease or part of the same spectrum?
por: Santaniello, Maria, et al.
Publicado: (2022)

Current clinical management of constitutional delay of growth and puberty
por: Gaudino, Rossella, et al.
Publicado: (2022)

Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic
por: Koné-Paut, Isabelle, et al.
Publicado: (2020)

Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey
por: Minoia, Francesca, et al.
Publicado: (2022)

Multisystem Inflammatory Syndrome in Children (MIS-C) — Recent Updates
por: Sood, Mangla, et al.
Publicado: (2020)

Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Bhat, Chandrika S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mqf59ae55q50l1oj9uai5p0i9m